This topic contains 1 reply, has 1 voice, and was last updated by NIRAV AMIN 2 weeks, 5 days ago.
August 3, 2017 at 10:23 am #3757
Lupin:Rs. 993 ( on 03 August 2017)
India`s leading pharma company has shown impressive results in 2016-17 From the top of Rs. 1734, the scrip has declined to Rs. 985.In June quarter, the company earned topline of Rs. 2799 crores with bottomline of Rs. 354 crores.The scrip is just nearer to its bottom. You may watch out for the same and start accumulating the same .
Next update on this topic will be done on Thursday on 10 August 17
Forum members are requested to give their comments, observations on this scrip.
Last comment is visible at the bottom of this Topic-page.
Dr. Reddys:Rs. 2383 ( comment on 01 August 2017)
India`s leading pharma company has shown impressive results in 2016-17 with Net profit of Rs. 1347 crores on total income of Rs. 9720 crores. The Earning per share comes to Rs. 81. The scrip has declined from 52 Weeks top of Rs. 3580 to near bottom-price of Rs. 2383. The scrip is just nearer to its bottom. You may watch out for the same.
August 3, 2017 at 3:19 pm #7204
B.NANJI ENTERPRISE LTD.
THE above company is ready to move out from double figure to triple figure ion this BULL PHASE. After RERA Company has very good potential. Promoters have huge land bank around western part of INDIA and they will start developing MORE BETTER REAL ESTATE PROJECTS in future.
those who believe BUY AT CURRENT PRICE AROUND 13.
TIME WILL TELL THE REST STORY OF SUCCESS….